Hepion Pharmaceuticals Ownership 2024 | Who Owns Hepion Pharmaceuticals Now?
Institutional Ownership
183.50%
Insider Ownership
0.10%
Retail Ownership
-83.61%
Institutional Holders
27.00
Hepion Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -528 | -100.00% | - | Jun 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -132,059 | -100.00% | - | Jun 30, 2023 |
STATE STREET CORP | - | - | - | -313,500 | -100.00% | - | Jun 30, 2023 |
VANGUARD GROUP INC | - | - | - | -3,310,180 | -100.00% | - | Jun 30, 2023 |
PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -57,534 | -100.00% | - | Jun 30, 2023 |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -31,535 | -100.00% | - | Jun 30, 2023 |
MORGAN STANLEY | - | - | - | -88,216 | -100.00% | - | Jun 30, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -13,128 | -100.00% | - | Jun 30, 2023 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -284,300 | -100.00% | - | Jun 30, 2023 |
AMUSSEN HUNSAKER ASSOCIATES LLC | - | - | - | -13,306 | -100.00% | - | Jun 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -656,453 | -100.00% | - | Jun 30, 2023 |
BLACKROCK INC. | - | - | - | -1,602,772 | -100.00% | - | Jun 30, 2023 |
BANK OF NEW YORK MELLON CORP | - | - | - | -88,715 | -100.00% | - | Jun 30, 2023 |
ENVESTNET ASSET MANAGEMENT INC | - | - | - | -156,909 | -100.00% | - | Jun 30, 2023 |
CITADEL ADVISORS LLC | - | - | - | -1,648 | -100.00% | - | Jun 30, 2023 |
SIGNATUREFD, LLC | - | - | - | -2 | -100.00% | - | Jun 30, 2023 |
HARBOR INVESTMENT ADVISORY, LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2023 |
TWO SIGMA ADVISERS, LP | - | - | - | -25,900 | -100.00% | - | Jun 30, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -10,564 | -100.00% | - | Jun 30, 2023 |
VIRTU FINANCIAL LLC | - | - | - | -53,501 | -100.00% | - | Jun 30, 2023 |
Hepion Pharmaceuticals's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
WELLS FARGO & COMPANY/MN | - | - | - | -528 | -100.00% | - | Jun 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -132,059 | -100.00% | - | Jun 30, 2023 |
STATE STREET CORP | - | - | - | -313,500 | -100.00% | - | Jun 30, 2023 |
VANGUARD GROUP INC | - | - | - | -3,310,180 | -100.00% | - | Jun 30, 2023 |
PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -57,534 | -100.00% | - | Jun 30, 2023 |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -31,535 | -100.00% | - | Jun 30, 2023 |
MORGAN STANLEY | - | - | - | -88,216 | -100.00% | - | Jun 30, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -13,128 | -100.00% | - | Jun 30, 2023 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -284,300 | -100.00% | - | Jun 30, 2023 |
AMUSSEN HUNSAKER ASSOCIATES LLC | - | - | - | -13,306 | -100.00% | - | Jun 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -656,453 | -100.00% | - | Jun 30, 2023 |
BLACKROCK INC. | - | - | - | -1,602,772 | -100.00% | - | Jun 30, 2023 |
BANK OF NEW YORK MELLON CORP | - | - | - | -88,715 | -100.00% | - | Jun 30, 2023 |
ENVESTNET ASSET MANAGEMENT INC | - | - | - | -156,909 | -100.00% | - | Jun 30, 2023 |
CITADEL ADVISORS LLC | - | - | - | -1,648 | -100.00% | - | Jun 30, 2023 |
SIGNATUREFD, LLC | - | - | - | -2 | -100.00% | - | Jun 30, 2023 |
HARBOR INVESTMENT ADVISORY, LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2023 |
TWO SIGMA ADVISERS, LP | - | - | - | -25,900 | -100.00% | - | Jun 30, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -10,564 | -100.00% | - | Jun 30, 2023 |
VIRTU FINANCIAL LLC | - | - | - | -53,501 | -100.00% | - | Jun 30, 2023 |
The largest Hepion Pharmaceuticals shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Hepion Pharmaceuticals (HEPA), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ALLWORTH FINANCIAL LP | - | - | - | -1 | -100.00% | - | Jun 30, 2023 |
HARBOR INVESTMENT ADVISORY, LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2023 |
SIGNATUREFD, LLC | - | - | - | -2 | -100.00% | - | Jun 30, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -528 | -100.00% | - | Jun 30, 2023 |
CITADEL ADVISORS LLC | - | - | - | -1,648 | -100.00% | - | Jun 30, 2023 |
AMPLIUS WEALTH ADVISORS, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -10,564 | -100.00% | - | Jun 30, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -13,128 | -100.00% | - | Jun 30, 2023 |
AMUSSEN HUNSAKER ASSOCIATES LLC | - | - | - | -13,306 | -100.00% | - | Jun 30, 2023 |
UBS GROUP AG | - | - | - | -14,070 | -100.00% | - | Jun 30, 2023 |
CETERA INVESTMENT ADVISERS | - | - | - | -19,746 | -100.00% | - | Jun 30, 2023 |
TWO SIGMA ADVISERS, LP | - | - | - | -25,900 | -100.00% | - | Jun 30, 2023 |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -31,535 | -100.00% | - | Jun 30, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -47,524 | -100.00% | - | Jun 30, 2023 |
VIRTU FINANCIAL LLC | - | - | - | -53,501 | -100.00% | - | Jun 30, 2023 |
PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -57,534 | -100.00% | - | Jun 30, 2023 |
MCADAM, LLC | - | - | - | -62,169 | -100.00% | - | Jun 30, 2023 |
MORGAN STANLEY | - | - | - | -88,216 | -100.00% | - | Jun 30, 2023 |
BANK OF NEW YORK MELLON CORP | - | - | - | -88,715 | -100.00% | - | Jun 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -132,059 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Hepion Pharmaceuticals's largest institutional buyer is ALLWORTH FINANCIAL LP. The company purchased -1.00 stocks of HEPA, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VANGUARD GROUP INC | - | - | - | -3,310,180 | -100.00% | - | Jun 30, 2023 |
BLACKROCK INC. | - | - | - | -1,602,772 | -100.00% | - | Jun 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -656,453 | -100.00% | - | Jun 30, 2023 |
STATE STREET CORP | - | - | - | -313,500 | -100.00% | - | Jun 30, 2023 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -284,300 | -100.00% | - | Jun 30, 2023 |
ENVESTNET ASSET MANAGEMENT INC | - | - | - | -156,909 | -100.00% | - | Jun 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -132,059 | -100.00% | - | Jun 30, 2023 |
BANK OF NEW YORK MELLON CORP | - | - | - | -88,715 | -100.00% | - | Jun 30, 2023 |
MORGAN STANLEY | - | - | - | -88,216 | -100.00% | - | Jun 30, 2023 |
MCADAM, LLC | - | - | - | -62,169 | -100.00% | - | Jun 30, 2023 |
PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -57,534 | -100.00% | - | Jun 30, 2023 |
VIRTU FINANCIAL LLC | - | - | - | -53,501 | -100.00% | - | Jun 30, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -47,524 | -100.00% | - | Jun 30, 2023 |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -31,535 | -100.00% | - | Jun 30, 2023 |
TWO SIGMA ADVISERS, LP | - | - | - | -25,900 | -100.00% | - | Jun 30, 2023 |
CETERA INVESTMENT ADVISERS | - | - | - | -19,746 | -100.00% | - | Jun 30, 2023 |
UBS GROUP AG | - | - | - | -14,070 | -100.00% | - | Jun 30, 2023 |
AMUSSEN HUNSAKER ASSOCIATES LLC | - | - | - | -13,306 | -100.00% | - | Jun 30, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -13,128 | -100.00% | - | Jun 30, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -10,564 | -100.00% | - | Jun 30, 2023 |
As of Jun 30 2023, Hepion Pharmaceuticals's biggest institutional seller is VANGUARD GROUP INC. The company sold -3.31M shares of HEPA, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VANGUARD GROUP INC | - | - | - | -3,310,180 | -100.00% | - | Jun 30, 2023 |
BLACKROCK INC. | - | - | - | -1,602,772 | -100.00% | - | Jun 30, 2023 |
GEODE CAPITAL MANAGEMENT, LLC | - | - | - | -656,453 | -100.00% | - | Jun 30, 2023 |
STATE STREET CORP | - | - | - | -313,500 | -100.00% | - | Jun 30, 2023 |
RENAISSANCE TECHNOLOGIES LLC | - | - | - | -284,300 | -100.00% | - | Jun 30, 2023 |
ENVESTNET ASSET MANAGEMENT INC | - | - | - | -156,909 | -100.00% | - | Jun 30, 2023 |
NORTHERN TRUST CORP | - | - | - | -132,059 | -100.00% | - | Jun 30, 2023 |
BANK OF NEW YORK MELLON CORP | - | - | - | -88,715 | -100.00% | - | Jun 30, 2023 |
MORGAN STANLEY | - | - | - | -88,216 | -100.00% | - | Jun 30, 2023 |
MCADAM, LLC | - | - | - | -62,169 | -100.00% | - | Jun 30, 2023 |
PNC FINANCIAL SERVICES GROUP, INC. | - | - | - | -57,534 | -100.00% | - | Jun 30, 2023 |
VIRTU FINANCIAL LLC | - | - | - | -53,501 | -100.00% | - | Jun 30, 2023 |
ADVISOR GROUP HOLDINGS, INC. | - | - | - | -47,524 | -100.00% | - | Jun 30, 2023 |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | - | - | - | -31,535 | -100.00% | - | Jun 30, 2023 |
TWO SIGMA ADVISERS, LP | - | - | - | -25,900 | -100.00% | - | Jun 30, 2023 |
CETERA INVESTMENT ADVISERS | - | - | - | -19,746 | -100.00% | - | Jun 30, 2023 |
UBS GROUP AG | - | - | - | -14,070 | -100.00% | - | Jun 30, 2023 |
AMUSSEN HUNSAKER ASSOCIATES LLC | - | - | - | -13,306 | -100.00% | - | Jun 30, 2023 |
GROUP ONE TRADING, L.P. | - | - | - | -13,128 | -100.00% | - | Jun 30, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | - | - | - | -10,564 | -100.00% | - | Jun 30, 2023 |
AMPLIUS WEALTH ADVISORS, LLC | - | - | - | -10,000 | -100.00% | - | Jun 30, 2023 |
CITADEL ADVISORS LLC | - | - | - | -1,648 | -100.00% | - | Jun 30, 2023 |
WELLS FARGO & COMPANY/MN | - | - | - | -528 | -100.00% | - | Jun 30, 2023 |
SIGNATUREFD, LLC | - | - | - | -2 | -100.00% | - | Jun 30, 2023 |
HARBOR INVESTMENT ADVISORY, LLC | - | - | - | -1 | -100.00% | - | Jun 30, 2023 |
ALLWORTH FINANCIAL LP | - | - | - | -1 | -100.00% | - | Jun 30, 2023 |
Hepion Pharmaceuticals's largest sold out institutional shareholder by shares sold is VANGUARD GROUP INC, sold -3.31M shares, valued at -, as of undefined.
Hepion Pharmaceuticals Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
VANGUARD VALLEY FORGE FUNDS | 0.12% | 59,700 | - | - | Dec 31, 2023 |
VANGUARD INDEX FUNDS | 0.01% | 3,161,576 | - | - | Dec 31, 2023 |
VANGUARD VALLEY FORGE FUNDS | 0.01% | 2,985 | - | - | Dec 31, 2023 |
FIDELITY CONCORD STREET TRUST | 0.00% | 611,890 | - | - | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 62,061 | - | - | Dec 31, 2023 |
FIDELITY COMMONWEALTH TRUST | 0.00% | 3,018 | - | - | Feb 29, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 31,535 | - | - | Feb 29, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 201,821 | 43,741 | 27.67% | Dec 31, 2023 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 3,104 | - | - | Dec 31, 2023 |
SCHWAB CAPITAL TRUST | 0.00% | 1,577 | - | - | Feb 29, 2024 |
iSHARES TRUST | 0.00% | 218,454 | - | - | Feb 29, 2024 |
EQ ADVISORS TRUST | 0.00% | 11,560 | - | - | Dec 31, 2023 |
Dimensional ETF Trust | 0.00% | 2,409 | - | - | Jan 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 688 | - | - | Jan 31, 2024 |
iSHARES TRUST | 0.00% | 2,798 | - | - | Feb 29, 2024 |
Hepion Pharmaceuticals's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 59.70K shares, compromising 0.12% of its total assets.
Hepion Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Mar, 23 | 27 | - |
31 Dec, 22 | 27 | 17.39% |
30 Sep, 22 | 23 | -11.54% |
30 Jun, 22 | 26 | -21.21% |
31 Mar, 22 | 33 | -13.16% |
31 Dec, 21 | 38 | 2.70% |
30 Sep, 21 | 37 | -19.57% |
30 Jun, 21 | 46 | 21.05% |
31 Mar, 21 | 38 | 35.71% |
31 Dec, 20 | 28 | 133.33% |
30 Sep, 20 | 12 | 140.00% |
30 Jun, 20 | 5 | -16.67% |
31 Mar, 20 | 6 | -45.45% |
31 Dec, 19 | 11 | 175.00% |
30 Sep, 19 | 4 | - |
As of 31 Mar 23, 27 institutions are holding Hepion Pharmaceuticals's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Mar, 23 | 6,994,261 | -0.65% |
31 Dec, 22 | 7,040,299 | 0.88% |
30 Sep, 22 | 6,979,223 | -4.42% |
30 Jun, 22 | 7,302,061 | -2.60% |
31 Mar, 22 | 7,496,957 | -3.87% |
31 Dec, 21 | 7,798,754 | 2.21% |
30 Sep, 21 | 7,630,225 | -26.88% |
30 Jun, 21 | 10,435,280 | 38.85% |
31 Mar, 21 | 7,515,357 | 38.98% |
31 Dec, 20 | 5,407,668 | 2042.97% |
30 Sep, 20 | 252,344 | 78.91% |
30 Jun, 20 | 141,044 | -32.38% |
31 Mar, 20 | 208,575 | 16.68% |
31 Dec, 19 | 178,755 | 14.82% |
30 Sep, 19 | 155,684 | - |
Hepion Pharmaceuticals (HEPA) has 6.99M shares outstanding as of 31 Mar 23, down -0.65% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Mar, 23 | 183.50% | 0.54% |
31 Dec, 22 | 184.71% | 0.55% |
30 Sep, 22 | 183.11% | 0.50% |
30 Jun, 22 | 191.58% | 0.50% |
31 Mar, 22 | 196.69% | 0.47% |
31 Dec, 21 | 204.61% | 0.51% |
30 Sep, 21 | 200.19% | 0.35% |
30 Jun, 21 | 240.13% | 0.80% |
31 Mar, 21 | 172.94% | 1.12% |
31 Dec, 20 | 124.44% | 369.04% |
30 Sep, 20 | 5.81% | 55.12% |
30 Jun, 20 | 3.25% | 14.09% |
31 Mar, 20 | 4.80% | 28.37% |
31 Dec, 19 | 4.11% | 20.24% |
30 Sep, 19 | 4.51% | - |
As of 31 Mar 23, Hepion Pharmaceuticals is held by 183.50% institutional shareholders, representing a 0.54% growth compared to 31 Dec 22.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Mar, 23 | 12 | -20.00% |
31 Dec, 22 | 15 | 66.67% |
30 Sep, 22 | 9 | - |
30 Jun, 22 | 9 | -35.71% |
31 Mar, 22 | 14 | -26.32% |
31 Dec, 21 | 19 | 46.15% |
30 Sep, 21 | 13 | -43.48% |
30 Jun, 21 | 23 | -25.81% |
31 Mar, 21 | 31 | 29.17% |
31 Dec, 20 | 24 | 140.00% |
30 Sep, 20 | 10 | 400.00% |
30 Jun, 20 | 2 | -50.00% |
31 Mar, 20 | 4 | -55.56% |
31 Dec, 19 | 9 | 125.00% |
30 Sep, 19 | 4 | - |
12 institutional shareholders have increased their position in HEPA stock as of 31 Mar 23 compared to 15 in the previous quarter (a -20.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Mar, 23 | 5 | -37.50% |
31 Dec, 22 | 8 | 60.00% |
30 Sep, 22 | 5 | -44.44% |
30 Jun, 22 | 9 | - |
31 Mar, 22 | 9 | - |
31 Dec, 21 | 9 | -30.77% |
30 Sep, 21 | 13 | 8.33% |
30 Jun, 21 | 12 | 300.00% |
31 Mar, 21 | 3 | 50.00% |
31 Dec, 20 | 2 | - |
30 Sep, 20 | - | -100.00% |
30 Jun, 20 | 1 | - |
31 Mar, 20 | 1 | -50.00% |
31 Dec, 19 | 2 | - |
30 Sep, 19 | - | - |
5 institutional shareholders have reduced their position in HEPA stock as of 31 Mar 23 compared to 8 in the previous quarter (a -37.50% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar, 23 | 27 | - | 6,994,261 | -0.65% | 183.50% | 0.54% | 12 | -20.00% | 5 | -37.50% |
31 Dec, 22 | 27 | 17.39% | 7,040,299 | 0.88% | 184.71% | 0.55% | 15 | 66.67% | 8 | 60.00% |
30 Sep, 22 | 23 | -11.54% | 6,979,223 | -4.42% | 183.11% | 0.50% | 9 | - | 5 | -44.44% |
30 Jun, 22 | 26 | -21.21% | 7,302,061 | -2.60% | 191.58% | 0.50% | 9 | -35.71% | 9 | - |
31 Mar, 22 | 33 | -13.16% | 7,496,957 | -3.87% | 196.69% | 0.47% | 14 | -26.32% | 9 | - |
31 Dec, 21 | 38 | 2.70% | 7,798,754 | 2.21% | 204.61% | 0.51% | 19 | 46.15% | 9 | -30.77% |
30 Sep, 21 | 37 | -19.57% | 7,630,225 | -26.88% | 200.19% | 0.35% | 13 | -43.48% | 13 | 8.33% |
30 Jun, 21 | 46 | 21.05% | 10,435,280 | 38.85% | 240.13% | 0.80% | 23 | -25.81% | 12 | 300.00% |
31 Mar, 21 | 38 | 35.71% | 7,515,357 | 38.98% | 172.94% | 1.12% | 31 | 29.17% | 3 | 50.00% |
31 Dec, 20 | 28 | 133.33% | 5,407,668 | 2042.97% | 124.44% | 369.04% | 24 | 140.00% | 2 | - |
30 Sep, 20 | 12 | 140.00% | 252,344 | 78.91% | 5.81% | 55.12% | 10 | 400.00% | - | -100.00% |
30 Jun, 20 | 5 | -16.67% | 141,044 | -32.38% | 3.25% | 14.09% | 2 | -50.00% | 1 | - |
31 Mar, 20 | 6 | -45.45% | 208,575 | 16.68% | 4.80% | 28.37% | 4 | -55.56% | 1 | -50.00% |
31 Dec, 19 | 11 | 175.00% | 178,755 | 14.82% | 4.11% | 20.24% | 9 | 125.00% | 2 | - |
30 Sep, 19 | 4 | - | 155,684 | - | 4.51% | - | 4 | - | - | - |
Hepion Pharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Hepion Pharmaceuticals's stock was made by Lbiati Kaouthar on Jul 20 2022, selling 60,000 shares at $0.69 per share (valued at $41.40K). The last insider buy of HEPA was made by Wijngaard Peter on Nov 28 2023, buying 2,500 shares at $3.05 per share (worth $7.63K).
Hepion Pharmaceuticals Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | 5 | - | - |
Q4 2023 | 2 | - | - |
Q3 2023 | 6 | - | - |
Q2 2022 | - | 2 | - |
Q2 2021 | 8 | - | - |
Q1 2021 | 3 | - | - |
Q4 2020 | 5 | - | - |
Q3 2020 | 8 | - | - |
Q2 2020 | 8 | - | - |
Q3 2019 | 7 | - | - |
Q1 2019 | - | 1 | - |
Q3 2018 | 8 | - | - |
Q1 2018 | 3 | - | - |
Q3 2017 | 5 | - | - |
Q2 2017 | 2 | 1 | 200.00% |
Q1 2017 | 2 | - | - |
Q4 2016 | 1 | 2 | 50.00% |
Q3 2016 | 6 | 3 | 200.00% |
Q2 2016 | 2 | 2 | 100.00% |
Q1 2016 | 1 | 2 | 50.00% |
5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Hepion Pharmaceuticals's insiders, as of Q1 2024.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q1 2024 | - | - | - |
Q4 2023 | 2 | - | - |
Q3 2023 | 6 | - | - |
Q2 2022 | - | - | - |
Q2 2021 | - | - | - |
Q1 2021 | 3 | - | - |
Q4 2020 | 5 | - | - |
Q3 2020 | - | - | - |
Q2 2020 | - | - | - |
Q3 2019 | - | - | - |
Q1 2019 | - | - | - |
Q3 2018 | 8 | - | - |
Q1 2018 | - | - | - |
Q3 2017 | - | - | - |
Q2 2017 | 1 | - | - |
Q1 2017 | - | - | - |
Q4 2016 | - | - | - |
Q3 2016 | - | - | - |
Q2 2016 | - | - | - |
Q1 2016 | 1 | - | - |
As of Q1 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Hepion Pharmaceuticals's stocks.
HEPA Ownership FAQ
Who Owns Hepion Pharmaceuticals?
Hepion Pharmaceuticals is owned by institutional shareholders (183.50%), insiders (0.10%), and public (-83.61%). The largest institutional shareholder of Hepion Pharmaceuticals is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.12% of total shares).
Who are the major institutional shareholders of Hepion Pharmaceuticals?
Hepion Pharmaceuticals's major institutional shareholders are WELLS FARGO & COMPANY/MN, NORTHERN TRUST CORP, STATE STREET CORP, VANGUARD GROUP INC, and PNC FINANCIAL SERVICES GROUP, INC.. The top five shareholders own together 0% of the company's share outstanding.
How many Hepion Pharmaceuticals shareholders are there?
As of Mar 2023, there are 27 institutional shareholders of Hepion Pharmaceuticals.
What percentage of Hepion Pharmaceuticals is owned by WELLS FARGO & COMPANY/MN?
WELLS FARGO & COMPANY/MN owns 0 shares of Hepion Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).
What percentage of Hepion Pharmaceuticals is owned by NORTHERN TRUST CORP?
As of Jun 2023, NORTHERN TRUST CORP holds 0 shares of Hepion Pharmaceuticals (HEPA), compromising 0% of the company, valued at $0.
What percentage of Hepion Pharmaceuticals is owned by STATE STREET CORP?
STATE STREET CORP is the third largest holder of Hepion Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).